These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8278409)

  • 1. A method to determine the ability of drugs to diffuse through the blood-brain barrier.
    Seelig A; Gottschlich R; Devant RM
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):68-72. PubMed ID: 8278409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Suomalainen P; Johans C; Söderlund T; Kinnunen PK
    J Med Chem; 2004 Mar; 47(7):1783-8. PubMed ID: 15027870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier permeation: molecular parameters governing passive diffusion.
    Fischer H; Gottschlich R; Seelig A
    J Membr Biol; 1998 Oct; 165(3):201-11. PubMed ID: 9767674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting blood-brain barrier penetration of drugs using an artificial neural network.
    Fu XC; Wang GP; Liang WQ; Yu QS
    Pharmazie; 2004 Feb; 59(2):126-30. PubMed ID: 15025181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The blood-brain barrier. II. Physiological data (conclusion)].
    Lefauconnier JM; Hauw JJ
    Rev Neurol (Paris); 1984; 140(2):89-109. PubMed ID: 6143382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter.
    Gerebtzoff G; Seelig A
    J Chem Inf Model; 2006; 46(6):2638-50. PubMed ID: 17125204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs.
    Kelder J; Grootenhuis PD; Bayada DM; Delbressine LP; Ploemen JP
    Pharm Res; 1999 Oct; 16(10):1514-9. PubMed ID: 10554091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionization-specific prediction of blood-brain permeability.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    J Pharm Sci; 2009 Jan; 98(1):122-34. PubMed ID: 18481317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic fast gradient liquid chromatography/tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery.
    Chu I; Liu F; Soares A; Kumari P; Nomeir AA
    Rapid Commun Mass Spectrom; 2002; 16(15):1501-5. PubMed ID: 12125028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of passive drug entry into the central nervous system.
    Habgood MD; Begley DJ; Abbott NJ
    Cell Mol Neurobiol; 2000 Apr; 20(2):231-53. PubMed ID: 10696512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption classification of oral drugs based on molecular surface properties.
    Bergström CA; Strafford M; Lazorova L; Avdeef A; Luthman K; Artursson P
    J Med Chem; 2003 Feb; 46(4):558-70. PubMed ID: 12570377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
    Grumetto L; Russo G; Barbato F
    Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms.
    Doniger S; Hofmann T; Yeh J
    J Comput Biol; 2002; 9(6):849-64. PubMed ID: 12614551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
    Bicker J; Alves G; Fortuna A; Falcão A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.